Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

What is already known about this topic?

Vaccination with hepatitis B (HepB) vaccines shows well-established safety and efficacy. However, because of risk factor−based approaches of previous vaccination recommendations, coverage among adults has been suboptimal.

What is added by this report?

In addition to groups for whom HepB vaccination is already recommended, the Advisory Committee on Immunization Practices recommends that all adults aged 19–59 years should receive HepB vaccines.

What are the implications for public health practice?

Universal adult HepB vaccination through age 59 years removes the need for risk factor screening and disclosure and could increase vaccination coverage and decrease hepatitis B cases.